Novel flexible heteroarotinoid, SL-1-39, inhibits HER2-positive breast cancer cell proliferation by promoting lysosomal degradation of HER2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel flexible heteroarotinoid, SL-1-39, inhibits HER2-positive breast cancer cell proliferation by promoting lysosomal degradation of HER2

Published:2019-02 Issue: Volume:443 Page:157-166
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zou Hongye,Sevigny Mary B.,Liu Shengquan,Madden David T.,Louie Maggie C.

Funder

Dominican University

School of Health and Natural Sciences Research

Touro University of California, College of Pharmacy, Intramural Research Award Program (IRAP)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference52 articles.

1. Recent progress in HER2 associated breast cancer;Wang;Asian Pac. J. Cancer Prev. APJCP,2015

2. HER2-directed therapy: current treatment options for HER2-positive breast cancer;Ahmed;Breast Canc.,2015

3. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;J. Clin. Oncol.,2013

4. HER2 testing and subsequent trastuzumab treatment for breast cancer in a managed care environment;Barron;Oncol.,2009

5. HER-2 testing in breast cancer using parallel tissue-based methods;Yaziji;JAMA,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anchoring of hyaluronan glycocalyx to CD44 reduces sensitivity of HER2‐positive gastric cancer cells to trastuzumab;The FEBS Journal;2024-01-26

2. Valency and affinity control of aptamer-conjugated nanoparticles for selective cancer cell targeting;Journal of Controlled Release;2023-03

3. Enantiomer of the novel flexible heteroarotinoid, SL-1-09, blocks cell cycle progression in breast cancer cells;European Journal of Pharmacology;2019-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3